Reversing EphB2 depletion rescues cognitive functions in Alzheimer model

Amyloid-β oligomers may cause cognitive deficits in Alzheimer’s disease by impairing neuronal NMDA-type glutamate receptors, whose function is regulated by the receptor tyrosine kinase EphB2. Here we show that amyloid-β oligomers bind to the fibronectin repeats domain of EphB2 and trigger EphB2 degradation in the proteasome. To determine the pathogenic importance of EphB2 depletions in Alzheimer’s disease and related models, we used lentiviral constructs to reduce or increase neuronal expression of EphB2 in memory centres of the mouse brain. In nontransgenic mice, knockdown of EphB2 mediated by short hairpin RNA reduced NMDA receptor currents and impaired long-term potentiation in the dentate gyrus, which are important for memory formation. Increasing EphB2 expression in the dentate gyrus of human amyloid precursor protein transgenic mice reversed deficits in NMDA receptor-dependent long-term potentiation and memory impairments. Thus, depletion of EphB2 is critical in amyloid-β-induced neuronal dysfunction. Increasing EphB2 levels or function could be beneficial in Alzheimer’s disease.

[1]  Anatol C. Kreitzer,et al.  Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer's Disease , 2007, Neuron.

[2]  T. Bonhoeffer,et al.  Kinase-Independent Requirement of EphB2 Receptors in Hippocampal Synaptic Plasticity , 2001, Neuron.

[3]  Shaomin Li,et al.  Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate Uptake , 2009, Neuron.

[4]  R. Wenthold,et al.  Distribution of Glutamate Receptor Subunit NMDAR1 in the Hippocampus of Normal Elderly and Patients with Alzheimer's Disease , 1999, Experimental Neurology.

[5]  P. Greengard,et al.  Regulation of NMDA receptor trafficking by amyloid-β , 2005, Nature Neuroscience.

[6]  M. Bear,et al.  LTP and LTD An Embarrassment of Riches , 2004, Neuron.

[7]  L. Mucke,et al.  Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation , 2004, Nature Medicine.

[8]  Kang Hu,et al.  High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation , 2000, The Journal of Neuroscience.

[9]  L. Mucke,et al.  Enkephalin Elevations Contribute to Neuronal and Behavioral Impairments in a Transgenic Mouse Model of Alzheimer's Disease , 2008, The Journal of Neuroscience.

[10]  J. Raber,et al.  Sex-differences in age-related cognitive decline in C57BL/6J mice associated with increased brain microtubule-associated protein 2 and synaptophysin immunoreactivity , 2006, Neuroscience.

[11]  Julie A. Harris,et al.  Many Neuronal and Behavioral Impairments in Transgenic Mouse Models of Alzheimer's Disease Are Independent of Caspase Cleavage of the Amyloid Precursor Protein , 2010, The Journal of Neuroscience.

[12]  Ryuichi Nakajima,et al.  Comprehensive behavioral phenotyping of calpastatin-knockout mice , 2008, Molecular Brain.

[13]  Roberto Malinow,et al.  Synaptic AMPA Receptor Plasticity and Behavior , 2009, Neuron.

[14]  L. Mucke,et al.  Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease , 2008, Nature Neuroscience.

[15]  L. Mucke,et al.  Androgens Protect against Apolipoprotein E4-Induced Cognitive Deficits , 2002, The Journal of Neuroscience.

[16]  Michael E Greenberg,et al.  EphB Receptors Interact with NMDA Receptors and Regulate Excitatory Synapse Formation , 2000, Cell.

[17]  A. Georgakopoulos,et al.  Ligand Binding and Calcium Influx Induce Distinct Ectodomain/γ-Secretase-processing Pathways of EphB2 Receptor* , 2007, Journal of Biological Chemistry.

[18]  L. Mucke,et al.  Accelerating Amyloid-β Fibrillization Reduces Oligomer Levels and Functional Deficits in Alzheimer Disease Mouse Models* , 2007, Journal of Biological Chemistry.

[19]  R. Malenka,et al.  Mechanisms underlying induction of long-term potentiation in rat medial and lateral perforant paths in vitro. , 1993, Journal of neurophysiology.

[20]  S. Squazzo,et al.  Evidence that production and release of amyloid beta-protein involves the endocytic pathway. , 1994, The Journal of biological chemistry.

[21]  W. Honer,et al.  Synapse alterations in the hippocampal-entorhinal formation in Alzheimer's disease with and without Lewy body disease , 1994, Brain Research.

[22]  David Baltimore,et al.  Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors , 2002, Science.

[23]  Shaomin Li,et al.  Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory , 2008, Nature Medicine.

[24]  R. Malinow,et al.  AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss , 2006, Neuron.

[25]  W. Klein Aβ toxicity in Alzheimer’s disease: globular oligomers (ADDLs) as new vaccine and drug targets , 2002, Neurochemistry International.

[26]  L. Mucke,et al.  Imbalance between GABAergic and Glutamatergic Transmission Impairs Adult Neurogenesis in an Animal Model of Alzheimer's Disease. , 2009, Cell stem cell.

[27]  Dominic M. Walsh,et al.  Deciphering the Molecular Basis of Memory Failure in Alzheimer's Disease , 2004, Neuron.

[28]  R. Malinow,et al.  APP Processing and Synaptic Function , 2003, Neuron.

[29]  L. Mucke,et al.  O4-06-05 Anti-amyloidogenic and neuroprotective functions of cathepsin B: Implications for Alzheimer’s disease , 2006, Alzheimer's & Dementia.

[30]  Bertrand Z. Yeung,et al.  Vulnerability of Dentate Granule Cells to Disruption of Arc Expression in Human Amyloid Precursor Protein Transgenic Mice , 2005, The Journal of Neuroscience.

[31]  Michel A. Picardo,et al.  GABAergic Hub Neurons Orchestrate Synchrony in Developing Hippocampal Networks , 2009, Science.

[32]  K. Zahs,et al.  Probing the Biology of Alzheimer's Disease in Mice , 2010, Neuron.

[33]  G. Collingridge,et al.  Age-Related Impairment of Synaptic Transmission But Normal Long-Term Potentiation in Transgenic Mice that Overexpress the Human APP695SWE Mutant Form of Amyloid Precursor Protein , 2001, The Journal of Neuroscience.

[34]  Jacob Raber,et al.  Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[35]  P. Greengard,et al.  Regulation of NMDA receptor trafficking by amyloid-beta. , 2005, Nature neuroscience.

[36]  F. Checler,et al.  M1 and M3 Muscarinic Receptors Control Physiological Processing of Cellular Prion by Modulating ADAM17 Phosphorylation and Activity , 2007, The Journal of Neuroscience.

[37]  R. Anwyl,et al.  NMDA receptor‐ and metabotropic glutamate receptor‐dependent synaptic plasticity induced by high frequency stimulation in the rat dentate gyrus in vitro , 2001, The Journal of physiology.

[38]  N. Burnashev,et al.  Non‐fibrillar β‐amyloid abates spike‐timing‐dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors , 2006, The European journal of neuroscience.

[39]  Jesús Avila,et al.  Early changes in hippocampal Eph receptors precede the onset of memory decline in mouse models of Alzheimer's disease. , 2009, Journal of Alzheimer's Disease.

[40]  Y. Dan,et al.  Burst Spiking of a Single Cortical Neuron Modifies Global Brain State , 2009, Science.

[41]  R M Pitkin,et al.  An embarrassment of riches. , 1989, Obstetrics and gynecology.

[42]  Joseph P Huston,et al.  Episodic-like memory in mice: simultaneous assessment of object, place and temporal order memory. , 2005, Brain research. Brain research protocols.

[43]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[44]  S. Scheff,et al.  Alzheimer's disease-related alterations in synaptic density: neocortex and hippocampus. , 2006, Journal of Alzheimer's disease : JAD.

[45]  John W. Gilbert,et al.  Cellular Prion Protein Mediates Impairment of Synaptic Plasticity by Amyloid-β Oligomers , 2009, Nature.

[46]  L. Mucke,et al.  Levels and Alternative Splicing of Amyloid β Protein Precursor (APP) Transcripts in Brains of APP Transgenic Mice and Humans with Alzheimer's Disease (*) , 1995, The Journal of Biological Chemistry.

[47]  E. Wagner,et al.  Impaired Long-Term Memory and NR2A-Type NMDA Receptor-Dependent Synaptic Plasticity in Mice Lacking c-Fos in the CNS , 2003, The Journal of Neuroscience.

[48]  Paul Greengard,et al.  Aβ-Mediated NMDA Receptor Endocytosis in Alzheimer's Disease Involves Ubiquitination of the Tyrosine Phosphatase STEP61 , 2010, The Journal of Neuroscience.

[49]  N. Ip,et al.  Bidirectional signaling of ErbB and Eph receptors at synapses. , 2008, Neuron glia biology.

[50]  M. Greenberg,et al.  Calcium Influx via the NMDA Receptor Induces Immediate Early Gene Transcription by a MAP Kinase/ERK-Dependent Mechanism , 1996, The Journal of Neuroscience.

[51]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[52]  R. Schwarcz,et al.  Reduction of Endogenous Kynurenic Acid Formation Enhances Extracellular Glutamate, Hippocampal Plasticity, and Cognitive Behavior , 2010, Neuropsychopharmacology.

[53]  M. Dalva,et al.  Modulation of NMDA Receptor- Dependent Calcium Influx and Gene Expression Through EphB Receptors , 2001, Science.

[54]  Young Ho Suh,et al.  An Essential Role for PICK1 in NMDA Receptor-Dependent Bidirectional Synaptic Plasticity , 2008, Neuron.

[55]  Bruno Bontempi,et al.  Selective Erasure of a Fear Memory , 2009, Science.

[56]  L. Martin,et al.  N-Methyl-d-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer’s disease , 2001, Journal of the Neurological Sciences.

[57]  L. Mucke,et al.  Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.

[58]  Jacob Raber,et al.  Hypothalamic–Pituitary–Adrenal Dysfunction inApoe−/− Mice: Possible Role in Behavioral and Metabolic Alterations , 2000, The Journal of Neuroscience.

[59]  E. Kandel,et al.  Strain-dependent differences in LTP and hippocampus-dependent memory in inbred mice. , 2000, Learning & memory.

[60]  L. Mucke,et al.  Antiamyloidogenic and Neuroprotective Functions of Cathepsin B: Implications for Alzheimer's Disease , 2006, Neuron.

[61]  R. Motter,et al.  Amyloid precursor protein processing and Aβ42 deposition in a transgenic mouse model of Alzheimer disease , 1997 .

[62]  T. Pawson,et al.  The Receptor Tyrosine Kinase EphB2 Regulates NMDA-Dependent Synaptic Function , 2001, Neuron.